LSP TEAM » Bobojon Nazarov


Bobojon (‘Bobo’) Nazarov, Ph.D., MBA, joined LSP in 2018 as an Analyst. Bobo provides in-depth analytical support to the LSP investment team, with a prime focus on LSP’s investment activities in the public equity franchise. Prior to joining LSP, Bobo was an Analyst in the health care team of M Ventures, the corporate venture capital arm of Merck KGaA. At M Ventures he was involved in the entire investment process, from the initial screening of the deal flow, to the selection of investment opportunities followed by in-depth scientific and clinical due diligence. Before joining M Ventures, Bobo pursued an academic career where he earned his Ph.D., together with an MBA at University of Oxford via a unique 1+1 programme as an Engineering and Physical Sciences Research Council (EPSRC) and Pershing Square Scholar respectively (5 admitted Oxford students selected annually). Whilst in Oxford, his research focused on the mechanisms underlying cardiac disease including dissecting the mechanisms of pacemaking in the heart using his newly synthesised photo-affinity probes and pharmacological intervention with the aim of identifying novel targets. His findings were published multiple times and presented in number of conferences including at the Biophysical Society annual meetings (2014 and 2015). Prior to his research career in Oxford, Bobo embarked on a four-year career as a Financial Analyst in London where he honed his investment skills through structuring passive/active investment strategies, valuing exotic derivatives, and pricing spinout companies at Chicago Mercantile Exchange Group and HIS Markit. As Financial Analyst Bobo leveraged his multidisciplinary approach and contributed significantly to Markit’s revenue streams by proactively designing new products and entering new markets. Bobo graduated with a BSc (Hons) in Biomedical Sciences, an MSc in Finance, MSc in Pharmacology (Oxon), D.Phil. (Ph.D.) in Chemical Biology (Oxon), an MBA (Oxon) and, independently studied and passed Chartered Financial Analyst Levels I & II. Bobo is based in Amsterdam and can be contacted via e-mail oanmnebi@yfcip.pbz or call +31 (0) 20 664 55 00

Follow us

LSP TEAM » Bobojon Nazarov


Bobojon (‘Bobo’) Nazarov, Ph.D., MBA, joined LSP in 2018 as an Analyst. Bobo provides in-depth analytical support to the LSP investment team, with a prime focus on LSP’s investment activities in the public equity franchise. Prior to joining LSP, Bobo was an Analyst in the health care team of M Ventures, the corporate venture capital arm of Merck KGaA. At M Ventures he was involved in the entire investment process, from the initial screening of the deal flow, to the selection of investment opportunities followed by in-depth scientific and clinical due diligence. Before joining M Ventures, Bobo pursued an academic career where he earned his Ph.D., together with an MBA at University of Oxford via a unique 1+1 programme as an Engineering and Physical Sciences Research Council (EPSRC) and Pershing Square Scholar respectively (5 admitted Oxford students selected annually). Whilst in Oxford, his research focused on the mechanisms underlying cardiac disease including dissecting the mechanisms of pacemaking in the heart using his newly synthesised photo-affinity probes and pharmacological intervention with the aim of identifying novel targets. His findings were published multiple times and presented in number of conferences including at the Biophysical Society annual meetings (2014 and 2015). Prior to his research career in Oxford, Bobo embarked on a four-year career as a Financial Analyst in London where he honed his investment skills through structuring passive/active investment strategies, valuing exotic derivatives, and pricing spinout companies at Chicago Mercantile Exchange Group and HIS Markit. As Financial Analyst Bobo leveraged his multidisciplinary approach and contributed significantly to Markit’s revenue streams by proactively designing new products and entering new markets. Bobo graduated with a BSc (Hons) in Biomedical Sciences, an MSc in Finance, MSc in Pharmacology (Oxon), D.Phil. (Ph.D.) in Chemical Biology (Oxon), an MBA (Oxon) and, independently studied and passed Chartered Financial Analyst Levels I & II. Bobo is based in Amsterdam and can be contacted via e-mail oanmnebi@yfcip.pbz or call +31 (0) 20 664 55 00